Printer Friendly

JONES MEDICAL COMPLETES ACQUISITION OF BRONSON PHARMACEUTICALS

 ST. LOUIS, March 25 /PRNewswire/ -- Jones Medical Industries, Inc. (NASDAQ: JMED) today completed the acquisition of Bronson Pharmaceuticals for $10.5 million in cash.
 Bronson Pharmaceuticals is a 33 year old consumer products marketing company located in La Canada (Los Angeles), California with 1992 sales of Nutritional and OTC Pharmaceutical products of $15.4 million. Bronson has 60 employees including a broad based management team headed up by Michael Irwin, CEO, and Ray Hensley, President. Mr. Irwin has an extensive background in direct response marketing and Mr. Hensley has over 30 years experience in the pharmaceutical industry. The company has over 150 products marketed primarily by direct response marketing to over 400,000 consumers, physicians and pharmacies throughout the United States and Canada.
 Mr. Michael Bramblett, JMED's vice president of marketing and corporate development said, "After holding firm for two years to our acquisition strategies, it is gratifying to close two transactions within the first quarter of 1993. The February 1993 acquisition of the $2.4 million Derma System product line, together with Bronson Pharmaceuticals' sales, will result in JMED's sales exceeding $40 million for 1993. Further, the inherent efficiencies from the consolidation of these two acquisitions should have a tremendously favorable impact on future earnings."
 -0- 3/25/93
 /CONTACT: Jones Medical Industries, Inc. investor relations, 314-432-7557/
 (JMED)


CO: Jones Medical Industries, Inc.; Bronson Pharmaceuticals ST: Missouri, California IN: MTC SU: TNM

TS -- NY030 -- 9491 03/25/93 10:30 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 25, 1993
Words:242
Previous Article:SHERMAN JOINS M. A. SCHAPIRO & CO., INC. AS DIRECTOR OF RESEARCH
Next Article:EBASCO/BNFL INC. TEAM SELECTED BY DOE FOR $100 MILLION EFFORT AT HANFORD
Topics:


Related Articles
IVAX ACQUIRES DVM PHARMACEUTICALS, INC.
IVAX COMPLETES ACQUISITION OF LUCHEM PHARMACEUTICALS, INC.
IVAX COMPLETES ACQUISITION OF CERTAIN ASSETS OF THE U.K. GENERIC PHARMACEUTICAL OPERATIONS OF MEDEVA PLC
JONES MEDICAL REPORTS UNUSUALLY LARGE APRIL 1993 THROMBINAR SALES
JONES MEDICAL REPORTS RECORD FIRST QUARTER WITH NET INCOME UP 16 PERCENT
JONES MEDICAL POST 66% NET INCOME GAIN FOR YEAR
JONES MEDICAL DISCUSSES EARLY 1994 RESULTS AT MABON CONFERENCE
JONES MEDICAL REPORTS FIRST QUARTER 1994 EARNINGS
Jones & Bartlett acquires Tarascon Publishing.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters